eight were immunised in the upper arm, 10 in the buttock, and three in the thigh. The injection was given with a 23 gauge needle. Whenever possible pressure was applied to the vaccination site for one to two minutes after the injection. Six of the 153 injections (4%) resulted in bruising, none severe enough to warrant an injection of concentrate. Three children had repeated attacks of vomiting, which began a few hours after the first dose in two and two days after the third dose in the third. One child had a febrile illness with myalgia two days after the third dose of vaccine. There were no other reactions. We did not routinely measure titres of hepatitis B antibody.
Comment
The manufacturer's data sheet for hepatitis B vaccine has always stated that the vaccine is for intramuscular use only and should not be given intravenously, subcutaneously, or intradermally. We therefore decided to give it by intramuscular injection. Others have given the vaccine subcutaneously' 3 or intravenously4 because of the theoretical risk of bleeding. No differences were reported between haemophiliacs given subcutaneous' or intravenous4 injections and normal controls. Ofthe 11 haemophiliacs who responded to a questionnaire in a study by Janco,2 two (18%) complained of soreness or swelling at the site of injection. In a series of 1083 homosexual men injected intramuscularly the incidence of sore arms was 15-8%.5 The incidence of bruising in our series was lower (4%). The difference may be due to the fact that in the other series the incidence of side effects was estimated by means of a questionnaire whereas in our series it was established by routine questions at follow up visits. Furthermore, we studied only children, who would perhaps be unlikely to complain to their parents about sore arms for fear of a further injection. None was needed-an important fact at a time of anxiety about the safety of clotting factor concentrates. The point we wish to make, however, is that there were no serious bruises and no treatment was needed for haematoma induced by intramuscular injection.
The increased dramatically (40%, 95% confidence interval 25% to 56%) during 1982-7. In contrast, the rate among men aged 25-34 and 35-44, which increased steeply during the late 1970s and early 'eighties,5 seems to have stabilised and may even have started to fall. The suicide rate among women seems to have been falling throughout the period of the study, a finding that represents a continuation of earlier trends.5
As in our previous study4 our analysis permits no inference about the causes of changing suicide rates among young men. Changing patterns of drug and alcohol use, psychiatric ill health, and a vast array of possible social factors may all play an important part. It seems improbable that coroners throughout England and Wales have become more likely to return a verdict of suicide specifically in young men without any similar changes in relation to other age and sex groups; it therefore seems unlikely that our results are a consequence of recording artefact. The changes we have shown appear to be real, their magnitude is of considerable concern, and further study of the aetiology of these suicides is clearly needed.
ADDENDUM-The trend in suicides has since been emphasised by the mortality statistics for 1988, which show a further 18% increase (to 110 0 deaths per million per annum) in the suicide rate among men aged 15-24. The proportion ofpatients with a positive concentration of antibodies to cardiolipin among the patients receiving dialysis was significantly higher than that among the normal controls but about the same as that among the patients with systemic lupus erythematosus (table). Positive concentrations were, however, generally lower in the patients receiving dialysis than in those with systemic lupus erythematosus (mean 20 U/l (95% confidence interval 16 to 24 U/1) v 97 (34 to 160) U/1; p=0 001); the highest concentration in a patient receiving dialysis was 57 U/I compared with 200 U/l in a patient with systemic lupus erythematosus.
Among the patients receiving dialysis, having a positive antibody concentration was not associated with age or having received a transplant but was more common among the patients with chronic glomerulonephritis than among those with other diagnoses (table) . Three of six patients with lupus nephritis had positive antibody concentrations. A higher proportion of patients with chronic glomerulonephritis than with other renal disease had received a transplant, and they had also been receiving dialysis for longer. Neither
